Georgetown Lombardi Visiting Professor and Grand Rounds Lecture Series Featuring Katherine L. Nathanson, MD
“The Constantly Evolving Landscape of Inherited Breast Cancer”
Presented by:
Katherine L. Nathanson, MD
Professor of Medicine, Division of Translational Medicine and Human Genetics, and Genetics, Perelman School of Medicine at the University of Pennsylvania
Deputy Director, Abramson Cancer Center
Director of Genetics and Inaugural Chair, Pearl Basser Professorship for BRCA-Related Research, the Basser Center for BRCA
Location: Join this presenter in person in the New Research Building Auditorium (option to attend remotely via Zoom provided)
Sponsor: Laura Rozek, PhD
Katherine (Kate) L. Nathanson, MD, is a cancer geneticist, boarded in Internal Medicine and Clinical Genetics; she runs a research laboratory and has a busy clinical practice. Currently she is Professor at the Perelman School of Medicine at the University of Pennsylvania, and at the Abramson Cancer Center is the co-Leader of the Cancer Control Program and Chief Oncogenomics Physician. Dr. Nathanson has had extensive experience with molecular genotyping and analysis of genetic variants in relationship to cancer susceptibility and somatic genetics of cancer. She runs a translational research laboratory and has had a long term interest and published extensively on breast cancer genetics on topics including the identification of novel breast cancer susceptibility genes, characterization of cohorts that carry mutations in BRCA1/2 and genetic modifiers of breast cancer penetrance in BRCA1/2 mutation carriers, among others. Dr. Nathanson is a key contributor to the development of a large collection of DNA and tissue samples from high-risk family breast cancer cohorts, participating in several national and international consortium, including the Consortium of Identifiers of Modifiers of BRCA1/2 (CIMBA) and Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA). She has had a longstanding interest in the identification and characterization of moderate to high penetrance breast cancer susceptibility genes, which is the focus of her BCRF funded project.
Lecture Series Presented by Georgetown Lombardi Comprehensive Cancer Center